ST
GILD icon

Sabal Trust’s Gilead Sciences GILD Stock Holding History

Sabal Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,516
Closed -$204K – 222
2023
Q4 		$204K Buy
+2,516
New +$196K 0.01% 213
2015
Q3 		– Sell
-1,858
Closed -$218K – 107
2015
Q2 		$218K Sell
1,858
-2,100
-53% -$229K 0.03% 102
2015
Q1 		$388K Buy
+3,958
New +$402K 0.05% 83

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sabal Trust's GILD Position: Q1 2024 in Review

Sabal Trust sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 2,516 shares — an estimated $204K sold.

Sabal Trust first reported a position in GILD in Q1 2015 and held it in 3 quarters. The position peaked at $388K in Q1 2015. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Sabal Trust reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Sabal Trust sold 2,516 Gilead Sciences shares in Q1 2024, an estimated $204K.
  • Sabal Trust first reported a position in Gilead Sciences in Q1 2015 and held it in 3 quarters.
  • Sabal Trust's Gilead Sciences position peaked at $388K in Q1 2015.
  • 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Sabal Trust's 13F filing for Q1 2024, filed 6 May 2024.